Investigation the effects of silver nanoparticles and gold nanoparticles on expression of bap and csu genes in biofilm formation of Acinetobacter baumannii

Niloofar Rezania; Parisa Rahmati; Fatemeh Noorbakhsh; Nazanin Farhadyar; Ensieh Lotfali

doi:10.18502/ijm.v14i4.10237

Investigation the effects of silver nanoparticles and gold nanoparticles on expression of bap and csu genes in biofilm formation of Acinetobacter baumannii

Abstract

Background and Objectives: Acinetobacter baumannii is one of the main pathogens of the hospital and causes various infections. csu A/BABCDE involved in the initial surface attachment during biofilm formation and bap gene produces specific proteins at the cell surface that play a direct role in formation of biofilm and the infectivity of this bacterium. The aim of this study was to investigate the effect of silver nanoparticles and gold nanoparticles on the expression of bap and csu genes in the Acinetobacter baumannii biofilm formation.
Materials and Methods: The susceptibility test was performed to determine the MIC of silver nanoparticles, gold nanoparticles and gold- vancomycin nanoparticles performed by broth dilution method on A. baumannii strains. The ability of biofilms formation in strains treated by MIC of silver nanoparticles and gold- vancomycin nanoparticles were evaluated by microtiter plate method and A. baumannii ATCC19606 used as control. Expression of the csu and bap genes were determinded by measuring the cognate mRNA level by real-time PCR.
Results: In present study, gold nanoparticles could not prevent the growth and biofilm formation of A. baumannii strains. The MIC concentration of silver nanoparticles and vancomycin- gold nanoparticles were 6.25 μg/ml and 0.625 μg/ml respectively and MBC concenteration of nanoparticles for 70% of strain was 12.5 μg/ml and 1.25 μg/ml respectively. Real-time PCR and data analysis, determined that the expression of bap, csuC and csuE genes in A. baumannii strains treated with MIC concentration (6.25 μg/ml) of silver nanoparticles decreased compared to control groups. Also, the expression of csuC and csuE genes in strains treated with MIC concentration (0.625 μg/ml) of vancomycin -gold nanoparticles increased, however the expression of bap was decreased compared to the control groups.
Conclusion: Due to the inhibitory effect of silver nanoparticles and gold- vancomycin nanoparticles against A. baumannii biofilm formation and genes expression, they can probably be used for prevent of biofilm formation in medical instrument or can be use for treatment of infections with or without antibiotic.

1. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5: 939-951.
2. Lob SH, Hoban DJ, Sahm DF, Badal RE. Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii. Int J Antimicrob Agents 2016; 47: 317-323.
3. Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, et al. Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. JAMA 2014; 312: 1438-1446.
4. Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 2009; 4: 273-278.
5. Shahina M, Khaksar R. Investigation of antimicrobial effect and methods for determining the minimum inhibitory concentration of plant essential oils on pathogenic bacteria. Iran. J Nutr Sci Food Technol 2012; 7: 949-957.
6. Greene C, Wu J, Rickard AH, Xi C. Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces. Lett Appl Microbiol 2016; 63: 233-239.
7. Brossard KA, Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect Immun 2012; 80: 228-233.
8. Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol 2018; 16: 91-102.
9. Eze EC, Chenia H Y, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist 2018; 11: 2277-2299.
10. Cao Q, Wang Y, Chen F, Xia Y, Lou J, Zhang X, et al. A novel signal transduction pathway that modulates rhl quorum sensing and bacterial virulence in Pseudomonas aeruginosa. PLoS Pathog 2014; 10(8): e1004340.
11. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018; 18: 318-327.
12. Verma P, Tiwari M, Tiwari V. In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii. J Biomol Struct Dyn 2018; 36: 1182-1194.
13. Rai MK, Deshmukh SD, Ingle AP, Gade AK. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol 2012; 112: 841-852.
14. Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol 2018; 9: 1050-1074.
15. Teulon J M, Godon C, Chantalat L, Moriscot C, Cambedouzou J, Odorico M, et al. On the operational aspects of measuring nanoparticle sizes. Nanomaterials (Basel) 2018; 9: 18.
16. Stiufiuc R, Iacovita C, Lucaciu CM, Stiufiuc G, Dutu AG, Braescu C, et al. SERS-active silver colloids prepared by reduction of silver nitrate with short-chain polyethylene glycol. Nanoscale Res Lett 2013; 8: 47.
17. Taraszkiewicz A, Fila G, Grinholc M, Nakonieczna J. Innovative strategies to overcome biofilm resistance. Biomed Res Int 2013; 2013: 150653.
18. Jung J, Park W. Acinetobacter species as model microorganisms in environmental microbiology: current state and perspectives. Appl Microbiol Biotechnol 2015; 99: 2533-2548.
19. Singh R, Nadhe S, Wadhwani S, Shedbalkar U, Chopade BA. Nanoparticles for control of biofilms of Acinetobacter species. Materials (Basel) 2016; 9: 383.
20. Selasi GN, Nicholas A, Jeon H, Hyeon Na S, Kwon HIl, Kim YJ, et al. Differences in biofilm mass, expression of biofilm-associated genes, and resistance to desiccation between epidemic and sporadic clones of carbapenem-resistant Acinetobacter baumannii sequence type 191. PLoS One 2016; 11(9): e0162576.
21. Qin Z, Ou Y, Yang L, Zhu Y, Tolker-Nielsen T, Molin S, et al. Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology (Reading) 2007; 153: 2083-2092.
22. Dedeić-Ljubović A, Granov Đ, Hukić M. Emergence of extensive drug-resistant (XDR) Acinetobacter baumanniiin the clinical center university of Sarajevo, Bosnia and Herzegovina. Med Glas (Zenica) 2015; 12: 169-176.
23. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett 2008; 176: 1-12.
24. Aderibigbe BA. Metal-based nanoparticles for the treatment of infectious diseases. Molecules 2017; 22: 1370.
25. Gerber A, Bundschuh M, Klingelhofer D, Groneberg DA. Gold nanoparticles: recent aspects for human toxicology. J Occup Med Toxicol 2013; 8: 32.
26. Her S, Jaffray DA, Allen C. Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements. Adv Drug Deliv Rev 2017; 109: 84-101.
27. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology (Reading) 2003; 149: 3473-3484.
28. Azizi O, Shahcheraghi F, Salimizand H, Modarresi F, Shakibaie M R, Mansouri S, et al. Molecular analysis and expression of bap Gene in biofilm-forming multi-drug-resistant Acinetobacter baumannii. Rep Biochem Mol Biol 2016; 5: 62-72.
29. Hetta HF, Al-Kadmy IMS, Khazaal SS, Abbas S, Suhail A, El-Mokhtar M A, et al. Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii. Sci Rep 2021; 11: 10751.
30. Pourmbarak Mahnaie M, Mahmoudi H. Effect of glutathione-stabilized silver nanoparticles on expression of las I and las R of the genes in Pseudomonas aeruginosa strains. Eur J Med Res 2020; 25: 17.
31. Choi JS, Lee J W, Shin UC, Lee MW, Kim DJ, Kim SW. Inhibitory activity of silver nanoparticles synthesized using lycopersicon esculentum against biofilm formation in Candida species. Nanomaterials (Basel) 2019; 9: 1512.
32. Singh P, Pandit S, Mokkapati V, Garnæs J, Mijakovic I. A sustainable approach for the green synthesis of silver nanoparticles from solibacillus isronensis sp. and their application in biofilm inhibitio. Molecules 2020; 25: 2783.
33. Richter MF, Hergenrother PJ. The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics. Ann N Y Acad Sci 2019; 1435: 18-38.
34. Khan F, Manivasagan P, Lee JW, Pham DTN, Oh J, Kim YM. Fucoidan-stabilized gold nanoparticle-mediated biofilm inhibition, attenuation of virulence and motility properties in Pseudomonas aeruginosa PAO1. Mar Drugs 2019; 17: 208.

Files	XML PDF (914KB)
Issue	Vol 14 No 4 (2022)
Section	Original Article(s)
DOI	https://doi.org/10.18502/ijm.v14i4.10237
Keywords
Gold nanoparticles; Silver nanoparticles; Gene expression; Biofilm formation; Acinetobacter baumannii

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Rezania N, Rahmati P, Noorbakhsh F, Farhadyar N, Lotfali E. Investigation the effects of silver nanoparticles and gold nanoparticles on expression of bap and csu genes in biofilm formation of Acinetobacter baumannii. Iran J Microbiol. 2022;14(4):510-517.

Vancouver

Download Citation